A Phase I safety and immunogenicity trial of UBI(R) microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects

Author: Lambert J.S.   Keefer M.   Mulligan M.J.   Schwartz D.   Mestecky J.   Weinhold K.   Smith C.   Hsieh R.   Moldoveanu Z.   Fast P.   Forrest B.   Koff W.  

Publisher: Elsevier

ISSN: 0264-410X

Source: Vaccine, Vol.19, Iss.23, 2001-04, pp. : 3033-3042

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content